JPY 2808.0
(2.3%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 227.93 Billion JPY | 9.13% |
2022 | 208.85 Billion JPY | 26.11% |
2021 | 165.61 Billion JPY | 6.92% |
2020 | 154.9 Billion JPY | 40.33% |
2019 | 110.38 Billion JPY | 5.02% |
2018 | 105.1 Billion JPY | 12.49% |
2017 | 93.43 Billion JPY | 9.98% |
2016 | 84.94 Billion JPY | 3.45% |
2015 | 82.11 Billion JPY | 14.89% |
2014 | 71.47 Billion JPY | 16.49% |
2013 | 61.35 Billion JPY | 11.06% |
2012 | 55.24 Billion JPY | 13.39% |
2011 | 48.71 Billion JPY | 5.58% |
2010 | 46.14 Billion JPY | 18.19% |
2009 | 39.04 Billion JPY | 8.55% |
2008 | 35.96 Billion JPY | 14.2% |
2007 | 31.49 Billion JPY | 7.73% |
2006 | 29.23 Billion JPY | 20.84% |
2005 | 24.19 Billion JPY | -2.3% |
2004 | 24.76 Billion JPY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 62.56 Billion JPY | 4.96% |
2023 Q1 | 54.54 Billion JPY | -20.31% |
2023 FY | 227.93 Billion JPY | 9.13% |
2023 Q4 | 59.6 Billion JPY | -2.17% |
2023 Q3 | 60.92 Billion JPY | 15.29% |
2023 Q2 | 52.84 Billion JPY | -3.12% |
2022 FY | 208.85 Billion JPY | 26.11% |
2022 Q4 | 68.45 Billion JPY | 37.17% |
2022 Q2 | 45.12 Billion JPY | -0.54% |
2022 Q1 | 45.37 Billion JPY | 13.42% |
2022 Q3 | 49.9 Billion JPY | 10.59% |
2021 Q4 | 40 Billion JPY | -7.74% |
2021 Q2 | 39.32 Billion JPY | -8.39% |
2021 Q3 | 43.35 Billion JPY | 10.25% |
2021 Q1 | 42.92 Billion JPY | 8.27% |
2021 FY | 165.61 Billion JPY | 6.92% |
2020 Q2 | 36.74 Billion JPY | -3.06% |
2020 Q1 | 37.9 Billion JPY | 45.89% |
2020 FY | 154.9 Billion JPY | 40.33% |
2020 Q4 | 39.64 Billion JPY | -2.37% |
2020 Q3 | 40.61 Billion JPY | 10.54% |
2019 Q1 | 28.4 Billion JPY | 5.94% |
2019 Q3 | 29.05 Billion JPY | 7.83% |
2019 Q2 | 26.94 Billion JPY | -5.15% |
2019 FY | 110.38 Billion JPY | 5.02% |
2019 Q4 | 25.97 Billion JPY | -10.59% |
2018 Q1 | 25.49 Billion JPY | 10.76% |
2018 Q2 | 23.64 Billion JPY | -7.25% |
2018 FY | 105.1 Billion JPY | 12.49% |
2018 Q4 | 26.81 Billion JPY | -8.02% |
2018 Q3 | 29.15 Billion JPY | 23.29% |
2017 Q1 | 22.51 Billion JPY | 5.95% |
2017 Q4 | 23.01 Billion JPY | -10.48% |
2017 FY | 93.43 Billion JPY | 9.98% |
2017 Q3 | 25.71 Billion JPY | 15.91% |
2017 Q2 | 22.18 Billion JPY | -1.46% |
2016 Q3 | 23.18 Billion JPY | 13.94% |
2016 Q2 | 20.34 Billion JPY | 0.83% |
2016 FY | 84.94 Billion JPY | 3.45% |
2016 Q1 | 20.17 Billion JPY | -3.37% |
2016 Q4 | 21.24 Billion JPY | -8.33% |
2015 Q3 | 22.07 Billion JPY | 11.86% |
2015 Q1 | 19.43 Billion JPY | 5.51% |
2015 FY | 82.11 Billion JPY | 14.89% |
2015 Q4 | 20.88 Billion JPY | -5.4% |
2015 Q2 | 19.73 Billion JPY | 1.55% |
2014 Q1 | 16.48 Billion JPY | 2.23% |
2014 FY | 71.47 Billion JPY | 16.49% |
2014 Q4 | 18.41 Billion JPY | -5.98% |
2014 Q3 | 19.58 Billion JPY | 15.34% |
2014 Q2 | 16.98 Billion JPY | 3.01% |
2013 Q4 | 16.12 Billion JPY | -3.24% |
2013 FY | 61.35 Billion JPY | 11.06% |
2013 Q1 | 14.6 Billion JPY | 7.89% |
2013 Q2 | 13.95 Billion JPY | -4.46% |
2013 Q3 | 16.66 Billion JPY | 19.44% |
2012 Q1 | 13.75 Billion JPY | 10.89% |
2012 Q2 | 12.98 Billion JPY | -5.58% |
2012 FY | 55.24 Billion JPY | 13.39% |
2012 Q3 | 14.96 Billion JPY | 15.21% |
2012 Q4 | 13.53 Billion JPY | -9.52% |
2011 Q2 | 11.41 Billion JPY | -1.91% |
2011 Q1 | 11.64 Billion JPY | -4.46% |
2011 Q3 | 13.25 Billion JPY | 16.08% |
2011 Q4 | 12.4 Billion JPY | -6.42% |
2011 FY | 48.71 Billion JPY | 5.58% |
2010 Q4 | 12.18 Billion JPY | 0.76% |
2010 Q2 | 10.92 Billion JPY | -0.08% |
2010 Q1 | 10.93 Billion JPY | 12.24% |
2010 FY | 46.14 Billion JPY | 18.19% |
2010 Q3 | 12.09 Billion JPY | 10.64% |
2009 Q3 | 10.23 Billion JPY | 6.49% |
2009 FY | 39.04 Billion JPY | 8.55% |
2009 Q1 | 9.46 Billion JPY | 1.78% |
2009 Q4 | 9.74 Billion JPY | -4.74% |
2009 Q2 | 9.6 Billion JPY | 1.53% |
2008 Q4 | 9.29 Billion JPY | -2.45% |
2008 Q1 | 8.33 Billion JPY | 0.0% |
2008 FY | 35.96 Billion JPY | 14.2% |
2008 Q3 | 9.53 Billion JPY | 8.25% |
2008 Q2 | 8.8 Billion JPY | 5.61% |
2007 FY | 31.49 Billion JPY | 7.73% |
2006 FY | 29.23 Billion JPY | 20.84% |
2005 FY | 24.19 Billion JPY | -2.3% |
2004 FY | 24.76 Billion JPY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 62.14 Billion JPY | -266.766% |
Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 94.654% |
Sumitomo Pharma Co., Ltd. | 314.55 Billion JPY | 27.538% |
Shionogi & Co., Ltd. | 435.08 Billion JPY | 47.611% |
Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -2845.483% |
Nippon Shinyaku Co., Ltd. | 148.25 Billion JPY | -53.745% |
Kaken Pharmaceutical Co., Ltd. | 72.04 Billion JPY | -216.382% |
Eisai Co., Ltd. | 741.75 Billion JPY | 69.271% |
Morishita Jintan Co., Ltd. | 12.4 Billion JPY | -1737.288% |
Hisamitsu Pharmaceutical Co., Inc. | 141.7 Billion JPY | -60.85% |
Mochida Pharmaceutical Co., Ltd. | 102.88 Billion JPY | -121.542% |
Fuso Pharmaceutical Industries,Ltd. | 55.4 Billion JPY | -311.389% |
Nippon Chemiphar Co., Ltd. | 30.74 Billion JPY | -641.297% |
Tsumura & Co. | 150.84 Billion JPY | -51.105% |
Kissei Pharmaceutical Co., Ltd. | 75.57 Billion JPY | -201.584% |
Torii Pharmaceutical Co., Ltd. | 54.63 Billion JPY | -317.171% |
Fuji Pharma Co., Ltd. | 40.88 Billion JPY | -457.446% |
Zeria Pharmaceutical Co., Ltd. | 75.72 Billion JPY | -201.002% |
KYORIN Holdings, Inc. | 119.53 Billion JPY | -90.689% |
Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -4422.5% |
Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | -386.052% |
SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -3977.744% |
MedRx Co., Ltd | 26 Million JPY | -876569.231% |
Mizuho Medy Co.,Ltd. | 10.98 Billion JPY | -1974.063% |
Solasia Pharma K.K. | 617 Million JPY | -36842.301% |
Modalis Therapeutics Corporation | - JPY | -Infinity% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | -262.704% |
Sawai Group Holdings Co., Ltd. | 176.86 Billion JPY | -28.877% |
Cyfuse Biomedical K.K. | 61.11 Million JPY | -372877.484% |
Toho Holdings Co., Ltd. | 1476.71 Billion JPY | 84.565% |
Koa Shoji Holdings Co.,Ltd. | 22.13 Billion JPY | -929.785% |